Literature DB >> 21651514

Clinical heterogeneity in Italian patients with amyotrophic lateral sclerosis.

I Piaceri1, M Del Mastio, A Tedde, S Bagnoli, S Latorraca, F Massaro, M Paganini, A Corrado, S Sorbi, B Nacmias.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a rare and devastating neurodegenerative disorder. The majority of cases are sporadic ALS (SALS), with 5-10% being familial ALS (FALS), and are inherited mostly as autosomal dominant. Mutations in Cu/Zn superoxide dismutase (SOD1) and the TAR DNA-binding protein (TARDBP) gene are the most commonly known cause of ALS. We analyzed these genes in 61 Italian ALS patients using high-resolution melting analysis to confirm the role of SOD1 and TARDBP in the physiopathology of ALS. The screenings showed a single mutation in SOD1 (Asp109Tyr) and three in TARBDP (Ala382Thr, Gly295Ser, Gly294Val) in five unrelated ALS patients. This report enlarges the spectrum of clinical phenotypes associated with genetic mutations in SOD1 and TARDBP genes confirming the variability of phenotypes associated with the same mutation and emphasizes the importance of genetic analysis. The different genotype-phenotype correlations suggest the implication of other factors possibly influencing clinical manifestation of the disease, such as an epigenetic or epistatic effect with other genes not yet identified.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21651514     DOI: 10.1111/j.1399-0004.2011.01726.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  6 in total

Review 1.  TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43.

Authors:  Tania F Gendron; Rosa Rademakers; Leonard Petrucelli
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  Genotype-phenotype association of TARDBP mutations in Chinese patients with amyotrophic lateral sclerosis: a single-center study and systematic review of published literature.

Authors:  Jinyue Li; Qing Liu; Xiaohan Sun; Kang Zhang; Shuangwu Liu; Zhili Wang; Xunzhe Yang; Mingsheng Liu; Liying Cui; Xue Zhang
Journal:  J Neurol       Date:  2022-03-03       Impact factor: 6.682

3.  High frequency of the TARDBP p.M337 V mutation among south-eastern Chinese patients with familial amyotrophic lateral sclerosis.

Authors:  Guo-Rong Xu; Wei Hu; Ling-Ling Zhan; Chong Wang; Liu-Qing Xu; Min-Ting Lin; Wan-Jin Chen; Ning Wang; Qi-Jie Zhang
Journal:  BMC Neurol       Date:  2018-04-05       Impact factor: 2.474

4.  Locomotor analysis identifies early compensatory changes during disease progression and subgroup classification in a mouse model of amyotrophic lateral sclerosis.

Authors:  Melissa M Haulcomb; Rena M Meadows; Whitney M Miller; Kathryn P McMillan; MeKenzie J Hilsmeyer; Xuefu Wang; Wesley T Beaulieu; Stephanie L Dickinson; Todd J Brown; Virginia M Sanders; Kathryn J Jones
Journal:  Neural Regen Res       Date:  2017-10       Impact factor: 5.135

5.  TARDBP mutations in a cohort of Italian patients with Parkinson's disease and atypical parkinsonisms.

Authors:  Cinzia Tiloca; Stefano Goldwurm; Narghes Calcagno; Federico Verde; Silvia Peverelli; Daniela Calini; Anna Lena Zecchinelli; Davide Sangalli; Antonia Ratti; Gianni Pezzoli; Vincenzo Silani; Nicola Ticozzi
Journal:  Front Aging Neurosci       Date:  2022-09-29       Impact factor: 5.702

6.  Insights into Amyotrophic Lateral Sclerosis from a Machine Learning Perspective.

Authors:  Jonathan Gordon; Boaz Lerner
Journal:  J Clin Med       Date:  2019-10-01       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.